Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies.
نویسندگان
چکیده
A total of 21 patients with hematologic malignancies were given thiabendazole for treatment of strongyloidiasis. Fifteen patients were cured. Since there were no relapses, it is unlikely that maintenance therapy has a role in the management of strongyloidiasis in this population of patients.
منابع مشابه
Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study.
To evaluate the efficacy of thiabendazole for prophylaxis of strongyloidiasis in patients with hematologic diseases, we performed a randomized, placebo-controlled trial. The incidence of strongyloidiasis was similar in both groups (p=0.36), but the compliance was better in the placebo group (p=0.04). This study does not support the use of thiabendazole prophylaxis in patients with hematologic d...
متن کاملMebendazole vs thiabendazole
In addition, cambendazole, but not thiabendazole or mebendazole, impaired the viability of S. ratti firstand second-stage larvae. The three drugs had no effect . Nov 4, 2016 . Thiabendazole was a therapeutic option for strongyloidiasis but has been discontinued. Albendazole and mebendazole have been used in patients with. For those too sick to tolerate or absorb oral (PO) ivermectin, rectal . J...
متن کاملFungal Infections in Pediatric Patients with Hematologic Malignancies
As the data on the epidemiology and outcome of fungal infections in children with hematologic cancer are limited especially in Iran, this study was aimed to delineate the epidemiologic features and outcome of fungal infections in this population. The medical records of all children with hematologic malignancies diagnosed with a fungal infection from 2005 to 2010 at a tertiary pediatric hospita...
متن کاملRandomized Clinical Trial on Ivermectin versus Thiabendazole for the Treatment of Strongyloidiasis
BACKGROUND Strongyloidiasis may cause a life-threatening disease in immunosuppressed patients. This can only be prevented by effective cure of chronic infections. Direct parasitologic exams are not sensitive enough to prove cure if negative. We used an indirect immune fluorescent antibody test (IFAT) along with direct methods for patient inclusion and efficacy assessment. METHODOLOGY/PRINCIPA...
متن کاملComplications of patients with hematologic malignancies in a selected Iranian population
Background: Hematologic malignancies in childhood and their treatments can cause dental anomalies and jaw bone abnormalities; therefore, the aim of this study was to assess the prevalence of these disorders in children. Methods: This cross-sectional study was conducted on all children diagnosed with hematologic malignancies that referred to in Amirkola Children’s Hospital from 2011 to 2018. Al...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
دوره 31 3 شماره
صفحات -
تاریخ انتشار 2000